Park Soon-jae
$2.59B
$38.4M (1.5%)
as of 04/20/26
About Park Soon-jae
Park Soon-jae is cofounder and CEO of South Korean biotechnology company Alteogen, which focuses on biosimilars and bio-betters.
Alteogen is known for its ALT-B4, an enzyme with technology that allows drugs to be administered subcutaneously instead of intravenously.
In 2024, Alteogen revealed Merck had agreed to a licensing deal to use ALT-B4 for the drug giant's cancer drug pembrolizumab. Alteogen shares soared 25% in a day following the announcement.
Park's wife, Chung Hye-shin, served as the company's chief strategy officer until 2023.
Personal stats
Citizenship
South KoreaSource of wealth
BiopharmaceuticalsResidence
Daejeon, South KoreaMarital status
MarriedBirth date
12/22/54 (age 71)Education
Ph.D, Purdue UniversitySelf-made
self-madePark Soon-jae’s fortune is worth
43K
troy ounces of gold
40K
median U.S. household
26K
median U.S. income
0.052%
U.S. credit card volume
0.01%
GDP of the United States
0.008%
United States debt
Net worth history
Annual ranking
Related people
Did you know?
Prior to cofounding Alteogen in 2008, Park worked at LG Life Sciences and Hanwha Petrochemical, and was a postdoctoral researcher at MIT.
Net worth over time
Real-time ranking
Financial assets
KOREA | 196170-KR
AlteogenImages © Forbes.com. All rights reserved.